Cupric oxide, or copper (II) oxide, is an inorganic compound with the chemical formula CuO. Cupric oxide is used as a precursor in many copper-containing products such as wood preservatives and ceramics. Cupric oxide may be found in over-the-counter vitamin-mineral supplements as a source of Copper. The mean daily dietary intake of copper in adults ranges between 0.9 and 2.2 mg . Common routes of cupric oxide exposure include ingestion, dermal exposure and inhalation. Copper(II) oxide nanoparticles (NPCuO) have industrial applications as antimicrobial agents in textiles and paints, and catalysts in organic synthesis . They may also be produced from electronic wastes. Cupric oxide poses potential health and environmental concern due to toxic and mutagenic particles generating reactive oxygen species .
Cupric oxide, or copper (II) oxide, is an inorganic compound with the chemical formula CuO. Cupric oxide is used as a precursor in many copper-containing products such as wood preservatives and ceramics. Cupric oxide may be found in over-the-counter vitamin-mineral supplements as a source of Copper. The mean daily dietary intake of copper in adults ranges between 0.9 and 2.2 mg . Common routes of cupric oxide exposure include ingestion, dermal exposure and inhalation. Copper(II) oxide nanoparticles (NPCuO) have industrial applications as antimicrobial agents in textiles and paints, and catalysts in organic synthesis . They may also be produced from electronic wastes. Cupric oxide poses potential health and environmental concern due to toxic and mutagenic particles generating reactive oxygen species .
No FDA- or EMA-approved therapeutic indications.
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|---|---|---|---|---|
ORAL | 2 mg in 1 1 | 2017/05/30 | 50090-0617 | ||
ORAL | 1 mg in 1 1 | 2024/02/02 | 52796-174 | ||
ORAL | 2 mg in 1 1 | 2023/03/14 | 0642-0093 | ||
ORAL | 2 mg in 1 1 | 2022/03/29 | 65162-668 | ||
ORAL | 1.5 mg in 1 1 | 2021/01/07 | 75854-314 | ||
ORAL | 1 mg in 1 1 | 2023/01/11 | 59088-182 | ||
ORAL | 2 mg in 1 1 | 2024/01/08 | 0178-0821 | ||
Marnel Pharmaceuticals, Inc. | ORAL | 3 mg in 1 1 | 2014/05/02 | 0682-3001 | |
ORAL | 1 mg in 1 1 | 2023/01/11 | 59088-181 | ||
ORAL | 2 mg in 1 1 | 2020/01/17 | 42192-320 |
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
317969 | Active | 2019/05/28 | cupric oxide | ||
404880 | Pharmacare Laboratories Pty Ltd | Active | 2023/02/15 | cupric oxide | |
343570 | Active | 2020/09/16 | cupric oxide | ||
343036 | Active | 2020/09/05 | cupric oxide | ||
468148 | Pharmacare Laboratories Pty Ltd | Active | 2024/11/12 | cupric oxide | |
354653 | Active | 2021/02/09 | cupric oxide | ||
429651 | Active | 2023/12/04 | cupric oxide | ||
407749 | Active | 2023/04/17 | cupric oxide | ||
396035 | Active | 2022/09/16 | cupric oxide | ||
386352 | Active | 2022/03/28 | cupric oxide |